DoW Autism Clinical Trial Award

The Defense Health Agency's FY26 Autism Research Program (ARP) Clinical Trial Award, with a total appropriation of $8.0M, seeks applications for clinical trials impacting autism treatment or management. Projects can range from pilot to large-scale trials, emphasizing community collaborations. A 'Partnering PI Option' offers increased funding for experienced PIs mentoring early-career investigators. Key deadlines are July 27, 2026, for pre-applications and October 22, 2026, for full applications. Eligibility extends to various organizations and independent investigators, with specific criteria for the Partnering PI option. The program encourages research in areas like improving diagnosis, interventions, and addressing mental/physical health in autistic individuals. Applicants must provide preliminary data, a clear statistical plan, and a post-award transition plan. The two-step application process involves eBRAP for pre-applications and either eBRAP or Grants.gov for full applications, depending on the organization type.

The FY26 Autism Research Program (ARP) Clinical Trial Award, offered by the Defense Health Agency, aims to fund clinical trials that significantly impact autism treatment or management. With an estimated $3.25 million, the program anticipates funding one single PI award ($1.5M cap) and one Partnering PI Option for Early-Career Investigator award ($1.75M cap), each with a maximum four-year performance period. Eligible applicants include U.S. and foreign, for-profit and non-profit organizations, with specific PI qualifications. Applications must address one of the FY26 ARP Clinical Trial Award Areas of Interest and are strongly encouraged to include community collaborations. A two-step application process involves a pre-application via eBRAP and a full application via eBRAP or Grants.gov, requiring detailed narratives, supporting documentation, and specific plans for intervention, recruitment, regulatory strategy, and post-award transition. The program emphasizes preliminary data, robust statistical analysis, and a clear plan for clinical impact and military relevance.

The FY26 Autism Research Program (ARP) Clinical Trial Award, sponsored by the Defense Health Agency, seeks applications for clinical trials impacting autism treatment and management. With approximately $3.25 million available, it funds one Clinical Trial Award ($1.50M cap) and one Partnering PI Option for Early-Career Investigator Award ($1.75M cap) over a maximum of four years. Eligibility extends to extramural and intramural U.S. Department of War organizations, with specific PI requirements, including a partnering option for early-career investigators. Key dates are July 27, 2026, for pre-applications and October 22, 2026, for full applications. The program prioritizes community collaborations and research aligned with specified areas of interest, requiring preliminary data and a clear transition plan for post-award development.